Lincoln Pharmaceuticals Ltd reports consolidated PAT of Rs. 27.67 crores in Q1 FY2025-26

Lincoln Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2025.

Financial Results (Q1 FY2026) - QoQ Comparison

The company has reported total income of Rs. 169.3384 crores during the period ended June 30, 2025 as compared to Rs. 161.3034 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs. 27.6752 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs. 11.5750 crores for the period ended March 31, 2025.

The company has reported EPS of Rs. 13.82 for the period ended June 30, 2025 as compared to Rs. 5.78 for the period ended March 31, 2025.

Financials	Q1 FY2026	Q4 FY2025	% Change
Total Income	₹ 169.3384 crs	₹161.3034 crs	4.98%
Net Profit	₹27.6752 crs	₹11.5750 crs	139.09%
EPS	₹13.82	₹5.78	139.10%

Financial Results (Q1 FY2026) - YoY Comparison

The company has reported total income of Rs. 169.3384 crores during the period ended June 30, 2025 as compared to Rs.157.6910 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs.27.6752 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs.23.6717 crores for the period ended June 30, 2024.

The company has reported EPS of Rs.13.82 for the period ended June 30, 2025 as compared to Rs.11.82 for the period ended June 30, 2024.

Financials	Q1 FY2026	Q1 FY2025	% Change
Total Income	₹ 169.3384 crs	₹157.6910 crs	7.39%
Net Profit	₹27.6752 crs	₹23.6717 crs	16.91%
EPS	₹13.82	₹11.82	16.92%

Shares of Lincoln Pharmaceuticals Limited was last trading in BSE at Rs. 604.10 as compared to the previous close of Rs. 531.85. The total number of shares traded during the day was 703278 in over 18764 trades.

The stock hit an intraday high of Rs. 624.80 and intraday low of 522.80. The net turnover during the day was Rs. 422834870.00.

Source : Equity Bulls

Keywords

LincolnPharmaceuticals Q1FY26 Q1FY2026 FY2026 ResultUpdate